UnitedHealth (UNH), once a reliable blue-chip stock, has seen its share price tumble about 55% from its 52-week high, reflecting heightened volatility. Investor confidence has been shaken by several setbacks, including rising medical costs, an unexpected CEO departure, and increased regulatory uncertainty tied to a recent executive order on drug pricing by former President Trump.…